Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 102, n° 11
pages 785-789 (novembre 2009)
Doi : 10.1016/j.acvd.2009.08.011
Received : 3 August 2009 ;  accepted : 4 August 2009
Challenging the dogma of high target doses in the treatment of heart failure: Is more always better?
Le dogme des hautes doses cibles pour le traitement de l’insuffisance cardiaque : est-il tenable ?
 

Figure 1




Figure 1 : 

Relative risks and 95% confidence intervals for mortality in low-dose and high-dose metoprolol patient subgroups in the MERIT-HF trial [19].


Figure 2




Figure 2 : 

Relationship between heart rates achieved by low and high doses of controlled-release metoprolol in the MERIT-HF trial [19].

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline